Follow

Ectin Research AB

Spotlight Stock Market (Sweden)

Ectin Research is a pharmaceutical company that is developing the drug candidate MFA-370. In preclinical studies, MFA-370 has shown promising potential in treatment therapy for metastatic bladder cancer and the cancers breast, colorectal and prostate cancers.

Sector:
HEALTH CARE
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ECTIN
SE0015987714
Spotlight Stock Market
Sweden (SE)
Details of share in Ectin Research AB with ticker ECTIN
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Aug 2021
Type
Price
Pre-money
Time
Files
IPO
5.90 SEK
29.87M SEK
01 Jul - 29 Jul 2021
IPO in Ectin Research AB
Type
Ticker
ISIN
Market
OPTION
ECTIN TO1 B
SE0015988357
Spotlight Stock Market
Sweden (SE)
Details of option in Ectin Research AB with ticker ECTIN TO1 B
Status
Active
Amount of instruments
Currency
SEK
First trading date
29 Jul 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 7.10.
Type
Price
Pre-money
Time
Files
Exercise
7.10 SEK
25 May - 15 Jun 2022
Option exercise terms for ECTIN TO1 B
People
Anna-Carin Sjöblom Hallén
CEO
Fredrik Sjövall
Chairman of the board
Carlos David Freitas De Sousa
Board member
Fredrik Andersson
Board member
Christer Edlund
Board member
Peter Falk
Board member
Anders Waas
Board member
Marie-Lois Ivarsson
Board member
Company Details
Sector
HEALTH CARE

Address
Pepparedsleden 1
Zip code
431 53
City/district
Mölndal
Country
Sweden (SE)
Registration number
556948-1566
LEI code
549300IDDKUG9RWXFN04
First trade date
Registration date
07 Nov 2013
Short name
Ectin

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More